Plenary keynote introduction will be
Comprehensive Kinase and Epigenetic Compound Profiling
by Kelvin Lam, PhD, Director, Strategic Partnerships, Reaction Biology Corporation.
Plenary keynote speaker: iPS Cell Technology, Gene Editing and Disease Research by
Rudolf Jaenisch, MD, Founding Member, Whitehead Institute for Biomedical Research; Professor, Department of Biology, Massachusetts Institute of Technology.
Second Plenary keynote speaker:
The Evolutionary Dynamics and Treatment of Cancer by
Martin Nowak, PhD, MSc, Professor, Biology and Mathematics and Director, Program for Evolutionary Dynamics, Harvard University.